Douglass Brian Robb — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Douglass Brian Robb has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Brian Robb Douglass is the Chief Product Officer of Repligen Corporation (RGEN) as of January 12, 2026, per SEC filings. The filing indicates he serves in the C-suite with no reported share purchases or sales in the disclosed filing.
Role
Insider
Notability
35/100
Board memberships
Repligen Corporation
Awards & honors
Leading product strategy for bioprocessing equipment
Oversight of product development for biologics manufacturing
Guiding cross-functional alignment between R&D, manufacturing, and commercial teams
Brian Robb Douglass is the Chief Product Officer of Repligen Corporation (RGEN) as of January 12, 2026, per SEC filings. The filing indicates he serves in the C-suite with no reported share purchases or sales in the disclosed filing.…
How many SEC Form 4 filings has Douglass Brian Robb submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Douglass Brian Robb's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
